(Z)-1-Ethoxy-2-(tributylstannyl)ethene
Product Information
Molecular Formula
C16H34OSn
Molecular Weight
361.15
Description
(Z)-1-Ethoxy-2-(tributylstannyl)ethene is a crucial compound in the biomedical industry primarily employed for research and development purposes. It is commonly used as a precursor or reagent in the synthesis of drugs targeting various diseases. Its unique structure allows for strategic modifications to create novel compounds with potential therapeutic effects.
Synonyms
(Z)-Tributyl[2-ethoxyethenyl]stannane,cis-1-Ethoxy-2-(tributylstannyl)ethylene,Tributyl((Z)-2-ethoxyvinyl)stannane
IUPAC Name
tributyl-[(Z)-2-ethoxyethenyl]stannane
SMILES
CCCC[Sn](CCCC)(CCCC)C=COCC
InChI
InChI=1S/C4H7O.3C4H9.Sn/c1-3-5-4-23*1-3-4-2/h1,3H,4H2,2H33*1,3-4H2,2H3
InChI Key
WARKYKQCOXTIAO-CHHAHMBLBK
Boiling Point
84-87 °C/1 mmHg
Flash Point
Not applicable
Purity
94%
Density
1.082 g/mL at 25 °C
Storage
2-8°C
Refractive Index
n20/D 1.479
Safety Information
Hazards
H301 - H312 - H315 - H319 - H372 - H410
Precautionary Statement
P273 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P305 + P351 + P338 - P314
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Rotatable Bond Count
12
Exact Mass
362.163168 g/mol
Monoisotopic Mass
362.163168 g/mol
Topological Polar Surface Area
9.2Ų
Heavy Atom Count
18
Formal Charge
0
Complexity
180
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
1
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021005586-A1 | Tricyclic akr1c3 dependent kars inhibitors | 2019-08-01 |
| JP-2021527113-A | Tricyclic AKR1C3-dependent KARS Inhibita | 2019-08-01 |
| TW-202120507-A | Tricyclic akr1c3 dependent kars inhibitors | 2019-08-01 |
| AU-2020309846-A1 | Tricyclic AKR1C3 dependent KARS inhibitors | 2019-08-01 |
| CA-3139940-A1 | Tricyclic akr1c3 dependent kars inhibitors | 2019-08-01 |
| CN-114206870-A | Tricyclic AKR1C3 dependent KARS inhibitors | 2019-08-01 |
| JP-7008161-B2 | Tricyclic AKR1C3 Dependent KARS Inhibita | 2019-08-01 |
| WO-2020216371-A1 | Egfr inhibitor and application thereof | 2019-04-26 |
| CN-111747950-A | Pyrimidine derivatives for the treatment of cancer | 2019-03-29 |
| WO-2020200158-A1 | N-heteroaromatic amide derivatives for treatment of cancer | 2019-03-29 |
